Effect of Quercetin Supplementation on Endometriosis Outcomes
Endometriosis
About this trial
This is an interventional supportive care trial for Endometriosis focused on measuring Quercetin, Endometriosis, Inflammation, Gonadal Steroid Hormones, Anthropometric, Adiponectin, Growth factor, Metabolic factors
Eligibility Criteria
Inclusion Criteria: Willing to cooperate and complete the informed consent form. Diagnosed endometriosis using laparoscopy and histopathological tests. In the age group of 18 to 40 years. Having a regular menstrual cycle. Having a body mass index between 18.5 and 30. Exclusion Criteria: Using hormonal medications or intrauterine treatments for a minimum of three months prior to collecting a sample. Having immune system disorders, persistent infections, diabetes, or any conditions like polyps and fibroids within the uterine cavity.
Sites / Locations
- National Nutrition and Food Technology Research InstituteRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Quercetin
Placebo
The intervention group will receive two 500 mg quercetin tablets daily, after breakfast and lunch, for twelve weeks.
The Placebogroup will receive Placebo tablets daily, after breakfast and lunch, for twelve weeks.